Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II everolimus in previously treated biliary tract cancer
2008-007152-94Phase 2Active
- Sponsor
- ITMO University
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of everolimus in biliary cancer, sponsored by ITMO University. Primary endpoints: Disease control rate and Objective response rate. Started Jan 2009; status: active.
02
Drugs
everolimus
03
Conditions
biliary cancer
Beyond the preview
Go deeper on 2008-007152-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007152-94.